Director, Center for Nanotechnology in Drug DeliveryMescal Swain Ferguson Distinguished Professor, UNC Eshelman School of PharmacyAdjunct Professor, UNC Department of Biomedical Engineering
University of North Carolina (UNC) at Chapel Hill
Chapel Hill, North Carolina, United States
Alexander “Sasha” Kabanov, Ph.D., D.Sc., is the Mescal S. Ferguson Distinguished Professor and director of the Center for Nanotechnology in Drug Delivery at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill.
His research focuses on several key areas.
Polymeric Micelles: Kabanov co-developed the first polymeric micelle drug that entered clinical trials for cancer treatment, thereby establishing polymeric micelles as a clinically approved drug delivery platform.
Polyplexes: Kabanov was among the first to use polycations and later, cationic block copolymers for delivering nucleic acids into cells. He evaluated core-shell polyelectrolyte complexes of nucleic acids and polypeptides, now known as “polyplexes”, for therapeutic drug and gene delivery.
Nanogels, Nanoparticle-Macrophage Carriers, and Exosomes: These have been utilized for delivering small drugs, nucleic acids, and polypeptides to treat cancers and diseases of the central nervous system.
Kabanov is a highly cited researcher, with over 340 scientific papers (garnering over 50,000 citations, and a Google h-index greater than 115), 36 US patents, and has co-founded several pharmaceutical companies. His cumulative research support in academia has been over $120 million.
Disclosure information not submitted.
The Upside and Downside of PEGylation and the Emerging Alternatives
Wednesday, July 10, 2024
9:00 AM – 11:00 AM CET
